Target Organs and Levels of Evidence for TR-503
Toxicology and Carcinogenesis Study of Chloral Hydrate (Ad Libitum and Dietary Controlled) (CASRN 302-17-0) in Male B6C3F1 Mice (Gavage Study)
| Chemical (Study Title) CASRN | Peer Review Date | Primary Uses | Route/Exposure Levels | Study Laboratory |
|---|---|---|---|---|
| Chloral hydrate 302-17-0 | 05/18/2000 | Medication: CNS depressant & sedative agent; in liniments; used in pediatrics; intermediate in plastics, pesticides. Also found in drinking water as result of chlorination. | Gavage 0, 25, 50, OR 100 MG/KG | National Center for Toxicological Research |
Levels of Evidence
Male Mice: Some Evidence
| Type | Organ/Tissue (Lesion) |
|---|---|
| Neoplastic Lesions |
|
